RISW2026
Back to all people

Qianyu Dang

FDA Center for Drug Evaluation and Research (CDER)
3 appearances in the program

Sessions & presentations

PS53: Non-clinical Statistical Methods to Support FDA's Initiative to Reduce Animal Testing
Presentation: Model Training and Validation – Lessons Learned from Using Human-induced Pluripotent Stem Cell-derived Cardiomyocytes (hiPSC-CMs) in Preclinical Cardiac Risk Evaluation
Parallel · Fri, Sep 18 , 2:50 PM
Panelist
PS53: Non-clinical Statistical Methods to Support FDA's Initiative to Reduce Animal Testing
Presentation: Model Training and Validation – Lessons Learned from Using Human-induced Pluripotent Stem Cell-derived Cardiomyocytes (hiPSC-CMs) in Preclinical Cardiac Risk Evaluation
Parallel · Fri, Sep 18 , 2:50 PM
Presenting Author